Ventas (NYSE:VTR) Stock Rating Upgraded by Raymond James Financial

Ventas (NYSE:VTR) was upgraded by analysts at Raymond James Financial to a “moderate buy” rating in a research note issued on Tuesday,Zacks.com reports.

Several other research firms also recently commented on VTR. Royal Bank Of Canada boosted their target price on shares of Ventas from $91.00 to $98.00 and gave the stock an “outperform” rating in a research report on Monday, May 4th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $100.00 target price on shares of Ventas in a research report on Tuesday. UBS Group boosted their target price on shares of Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research report on Monday, May 4th. Mizuho set a $98.00 target price on shares of Ventas in a research report on Friday, May 22nd. Finally, BMO Capital Markets reissued an “outperform” rating and issued a $100.00 target price on shares of Ventas in a research report on Monday, May 4th. Fifteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $96.41.

Ventas Stock Performance

Shares of VTR opened at $82.21 on Tuesday. The company’s 50 day moving average price is $85.15 and its 200 day moving average price is $82.58. Ventas has a 52 week low of $61.76 and a 52 week high of $91.06. The company has a market capitalization of $39.97 billion, a PE ratio of 149.48, a PEG ratio of 1.80 and a beta of 0.71. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25.

Ventas (NYSE:VTR) last announced its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The company had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same period in the previous year, the firm posted $0.84 earnings per share. The business’s revenue for the quarter was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Research analysts expect that Ventas will post 3.88 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the completion of the sale, the director directly owned 28,349 shares in the company, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler acquired 2,500 shares of Ventas stock in a transaction dated Wednesday, June 3rd. The stock was purchased at an average price of $78.81 per share, with a total value of $197,025.00. Following the completion of the purchase, the director directly owned 19,202 shares of the company’s stock, valued at $1,513,309.62. The trade was a 14.97% increase in their position. The SEC filing for this purchase provides additional information. 0.53% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Ventas

Several large investors have recently bought and sold shares of VTR. Dynamic Wealth Strategies LLC acquired a new position in Ventas during the 1st quarter valued at $25,000. GoalVest Advisory LLC acquired a new position in Ventas during the 4th quarter valued at $26,000. Wiser Advisor Group LLC acquired a new position in Ventas during the 3rd quarter valued at $27,000. IFC & Insurance Marketing Inc. acquired a new position in Ventas during the 4th quarter valued at $30,000. Finally, Elyxium Wealth LLC acquired a new position in Ventas during the 4th quarter valued at $33,000. 94.18% of the stock is currently owned by institutional investors and hedge funds.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.